Vacuolar H+-ATPase is down-regulated by the angiogenesis-inhibitory pigment epithelium-derived factor in metastatic prostate cancer cells

Cellular and Molecular Biology

Volumn 60, Issue 1, 2014, Pages 45-52

  Sennoune, S R ^a   Bermudez, L E ^a   Lees, J C ^a   Hirsch, J ^b   Filleur, S ^a,b   Martinez Zaguilan R ^a,c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Texas Tech University   (United States)

Author keywords

ATP6ap2; LNCaP and LNCaP derivative CL1 cells; pH regulation; Subunit a isoforms

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATP6AP2 PROTEIN; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; EYE PROTEIN; ISOPROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERINE PROTEINASE INHIBITOR;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL COMPARTMENTALIZATION; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENDOSOME; HUMAN; HUMAN CELL; LNCAP CELL LINE; LYSOSOME; METASTASIS; PH; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTON TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; CELL MEMBRANE; CELL PROLIFERATION; GENETICS; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; DOWN-REGULATION; EYE PROTEINS; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RNA, MESSENGER; SERPINS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84908544594     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.14715/cmb/2014.60.1.8     Document Type: Article

References (51)

1. Beyenbach, K. W., Wieczorek, H., The V-type H+ ATPase: molecular structure and function, physiological roles and regulation. J. Exp. Biol. 2006, 209: 577-589. doi: 10.1242/JEB.02014
2. Futai, M., Oka, T., Sun-Wada, G., Moriyama, Y., Kanazawa, H., Wada, Y.,Luminal acidification of diverse organelles by V-ATPase in animal cells. J. Exp. Biol. 2000, 203: 107-116.
3. Weisz, O. A., Acidification and protein traffic. Int. Rev. Cytol. 2003, 226: 259-319. doi: 10.1016/S0074-7696(03)01005-2
4. Forgac, M., Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol. 2007, 8: 917-929. doi: 10.1038/nrm2272
5. Martínez-Zaguilán, R., Martinez, G. M., Gomez, A., Hendrix, M. J. and Gillies, R. J., Distinct regulation of pHin and [Ca2+]in in human melanoma cells with different metastatic potential. J. Cell Physiol. 1998, 176: 196-205. doi: 10.1002/(SICI)1097-4652(199807)176:1<196::AID-JCP21>3.0.CO;2-4
6. Martínez-Zaguilán, R., Raghunand, N., Lynch, R. M., Bellamy, W., Martinez, G. M., Rojas, B., Smith, D., Dalton, W. S. and Gillies, R. J., pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. Biochem. Pharmacol. 1999, 57: 1037-1046. doi: 10.1016/S0006-2952(99)00022-2
7. Martínez-Zaguilán, R., Seftor EA, Seftor RE, Chu YW, Gillies RJ, Hendrix MJ., Acidic pH enhances the invasive behavior of human melanoma cells. Clin Exp Metastasis. 1996, 14: 176-186. doi: 10.1007/BF00121214
8. Nishi, T., Forgac, M., The vacuolar (H+)-ATPases--nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 2002, 3: 94-103. doi: 10.1038/nrm729
9. Toei, M., Saum, R. and Forgac, M., Regulation and isoform function of the V-ATPases,. Biochemistry. 2010, 49: 4715-4723. doi: 10.1021/bi100397s
10. Jansen, E. J., van Bakel, N. H., Coenen, A. J., van Dooren, S. H., van Lith, H. A., Martens, G. J., An isoform of the vacuolar (H(+))-ATPase accessory subunit Ac45. Cell Mol. Life Sci. 2010, 67: 629-640. doi: 10.1007/s00018-009-0200-6
11. Ludwig, J., Kerscher, S., Brandt, U., Pfeiffer, K., Getlawi, F., Apps, D. K., Schägger, H., Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 1998, 273: 10939-10947. doi: 10.1074/jbc.273.18.10939
12. Nishi, T., Forgac, M., Molecular cloning and expression of three isoforms of the 100-kDa a subunit of the mouse vacuolar proton-translocating ATPase. J. Biol. Chem. 2000, 275: 6824-6830. doi: 10.1074/jbc.275.10.6824
13. Pietrement, C., Sun-Wada, G. H., Silva, N. D., McKee, M., Marshansky, V., Brown, D., Futai, M., Breton, S., Distinct expression patterns of different subunit isoforms of the V-ATPase in the rat epididymis. Biol. Reprod. 2006, 74: 185-194. doi: 10.1095/biolreprod.105.043752
14. Scott, B. B., Chapman, C. G., The putative 116 kDa osteoclast specific vacuolar proton pump subunit has ubiquitous tissue distribution. Eur. J. Pharmacol 1998, 346: R3-4. doi: 10.1016/S0014-2999(98)00163-0
15. Kawasaki-Nishi, S., Bowers, K., Nishi, T., Forgac, M., and Stevens, T. H., The amino-terminal domain of the vacuolar proton-translocating ATPase a subunit controls targeting and in vivo dissociation, and the carboxyl-terminal domain affects coupling of proton transport and ATP hydrolysis. J biol chem 2001, 276: 47411-47420. doi: 10.1074/jbc.M108310200
16. Sun-Wada, G. H., Toyomura, T., Murata, Y., Yamamoto, A., Futai, M. and Wada, Y., The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. J. Cell Sci. 2006, 119: 4531-4540. doi: 10.1242/jcs.03234
17. Toyomura, T., Murata, Y., Yamamoto, A., Oka, T., Sun-Wada, G. H., Wada, Y. and Futai, M., From lysosomes to the plasma membrane: Localization of vacuolar-type H+-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem 2003, 278: 22023-22030. doi: 10.1074/jbc.M302436200
18. Toyomura, T., Oka, T., Yamaguchi, C., Wada, Y. and Futai, M., Three subunit a isoforms of mouse vacuolar H+-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J. Biol. Chem. 2000, 275: 8760-8765. doi: 10.1074/JBC.275.12.8760
19. Hinton, A., Sennoune, S. R., Bond, S., Fang, M., Reuveni, M., Sahagian, G. G., Jay, D., Martinez-Zaguilan, R., and Forgac, M., Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. J. Biol. Chem. 2009, 284: 16400-16408. doi: 10.1074/jbc.M901201200
20. Kane, P. M., Parra, K. J., Assembly and regulation of the yeast vacuolar H(+)-ATPase. J. Exp. Biol. 2000, 203: 81-87.
21. Advani, A., Kelly, D. J., Cox, A. J., White, K. E., Advani, S. L., Thai, K., Connelly, K. A., Yuen, D., Trogadis, J., Herzenberg, A. M., Kuliszewski, M. A., Leong-Poi, H., and Gilbert, R. E., The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 2009, 54: 261-269. doi: 10.1161/HYPERTENSIONAHA.109.128645
22. Kinouchi, K., Ichihara, A, Sano, M, Sun-Wada, GH, Wada, Y, Kurauchi-Mito, A, Bokuda, K, Narita, T, Oshima, Y, Sakoda, M, Tamai, Y, Sato, H, Fukuda, K, Itoh, H., The (Pro)renin receptor/ ATP6AP2 is essential for vacuolar H+ ATPase assembly in murine cardiomyocytes. Circ. Res. 2010, 107: 30-34. doi: 10.1161/CIRCRESAHA.110.224667
23. Buechling, T., Bartscherer, K., Ohkawara, B., Chaudhary, V., Spirohn, K., Niehrs, C., Boutros, M., Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr. Biol. 2010, 20, 1263-1268. doi: 10.1016/j.cub.2010.05.028
24. Nusse, R., Varmus, H. E., Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31: 99-109. doi: 10.1016/0092-8674(82)90409-3
25. Sennoune, S. R., and Martinez-Zaguilan, R., Vacuolar H(+)-ATPase signaling pathway in cancer. Curr Protein Pept Sci 2012, 13: 152-163. doi: 10.2174/138920312800493197
26. Clevers, H., Wnt/beta-catenin signaling in development and disease. Cell 2006, 127: 469-480. doi: 10.1016/j.cell.2006.10.018
27. Katoh, M., WNT/PCP signaling pathway and human cancer. Oncol. Rep. 2005, 14: 1583-1588.
28. Cruciat, C. M., Ohkawara, B., Acebron, S. P., Karaulanov, E., Reinhard, C., Ingelfinger, D., Boutros, M., Niehrs, C., Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 2010, 327: 459-463. doi: 10.1126/science.1179802
29. Marshansky, V., The V-ATPase a2-subunit as a putative endosomal pH-sensor. Biochem. Soc. Trans. 2007, 35: 1092-1099. doi: 10.1042/BST0351092
30. Tombran-Tink, J., and Barnstable, C. J., Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor. Trends Mol Med 2003, 9: 244-250. doi: 10.1016/S1471-4914(03)00074-1
31. Becerra, S. P., and Notario, V. , The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential. Nat Rev. Cancer 2013, 13: 258-271. doi: 10.1038/nrc3484
32. Steele, F. R., Chader, G. J., Johnson, L. V., and Tombran-Tink, J., Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA 1993, 90: 1526-1530. doi: 10.1073/pnas.904.1526
33. Becerra, S. P., Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv Exp Med Biol 1997, 425: 223-237. doi: 10.1007/978-1-4615-5391-5_21
34. Filleur, S., Volz, K., Nelius, T., Mirochnik, Y., Huang, H., Zaichuk, T. A., Aymerich, M. S., Becerra, S. P., Yap, R., Veliceasa, D., Shroff, E. H., and Volpert, O. V., Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res 2005, 65: 5144-5152. doi: 10.1158/0008-5472.CAN-04-3744
35. Doll, J. A., Stellmach, V. M., Bouck, N. P., Bergh, A. R., Lee, C., Abramson, L. P., Cornwell, M. L., Pins, M. R., Borensztajn, J., and Crawford, S. E., Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 2003, 9: 774-780. doi: 10.1038/nm870
36. Halin, S., Wikstrom, P., Rudolfsson, S. H., Stattin, P., Doll, J. A., Crawford, S. E., and Bergh, A., Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Can Res 2004, 64: 5664-5671. doi: 10.1158/0008-5472.CAN-04-0835
37. Nelius, T., Martinez-Marin, D., Hirsch, J., Miller, B., Rinard, K., Lopez, J., de Riese, W., and Filleur, S., Pigment Epithelium-Derived Factor Expression Prolongs Survival and Enhances the Cytotoxicity of Low-dose Chemotherapy in Castration-Refractory Prostate Cancer. Cell death Dis 2014, 5: e1210. doi: 10.1038/cddis.2014.180
38. Subramanian, P., Locatelli-Hoops, S., Kenealey, J., Desjardin, J., Notari, L., and Becerra, S. P., Pigment Epithelium-derived Factor (PEDF) Prevents Retinal Cell Death via PEDF Receptor (PEDF-R): IDENTIFICATION OF A FUNCTIONAL LIGAND BINDING SITE. J Biol Chem 2013, 288: 23928-23942. doi: 10.1074/jbc.M113.487884
39. Notari, L., Baladron, V., Aroca-Aguilar, J. D., Balko, N., Heredia, R., Meyer, C., Notario, P. M., Saravanamuthu, S., Nueda, M. L., Sanchez-Sanchez, F., Escribano, J., Laborda, J., and Becerra, S. P., Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor. J biol chem 2006, 281: 38022-38037. doi: 10.1074/jbc.M600353200
40. Bernard, A., Gao-Li, J., Franco, C. A., Bouceba, T., Huet, A., and Li, Z., Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol. Chem. 2009, 284: 10480-10490. doi: 10.1074/jbc.M809259200
41. Notari, L., Arakaki, N., Mueller, D., Meier, S., Amaral, J., and Becerra, S. P., Pigment epithelium-derived factor binds to cell-surface F(1)-ATP synthase. The FEBS J 2010, 277: 2192-2205. doi: 10.1111/j.1742-4658.2010.07641.x
42. Park, K., Lee K., Zhang, B., Zhou, T., He, X., Gao, G., Murray, A.R., Ma, J.X., Identification of a novel inhibitor of the canonical Wnt pathway. Mol. Cell Biol 2011, 31: 3038-3051. doi: 10.1128/MCB.01211-10
43. Tso, C. L., McBride, W. H., Sun, J., Patel, B., Tsui, K. H., Paik, S. H., Gitlitz, B., Caliliw, R., van Ophoven, A., Wu, L., deKernion, J., and Belldegrun, A., Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Cancer J 2000, 6: 220-233.
44. Sennoune, S. R., Bakunts, K., Martinez, G. M., Chua-Tuan, J. L., Kebir, Y., Attaya, M. N., and Martinez-Zaguilan, R., Vacuolar H+-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am J Physiol Cell Physiol 2004, 286: C1443-1452. doi: 10.1152/ajpcell.00407.2003
45. Roos, A., and Boron, W. F., Intracellular pH. Physiol Rev 1981, 61: 296-434.
46. Huss, M., and Wieczorek, H., Inhibitors of V-ATPases: old and new players. J. Exp. Biol. 2009, 212: 341-346. doi: 10.1242/jeb.024067
47. Hermle, T., Saltukoglu, D., Grunewald, J., Walz, G. and Simons, M., Regulation of Frizzled-dependent planar polarity signaling by a V-ATPase subunit. Curr Biol 2010, 20: 1269-1276. doi: 10.1016/j.cub.2010.05.057
48. Hermle, T., Petzoldt, A. G. and Simons, M., The role of proton transporters in epithelial Wnt signaling pathways. Pediatr. Nephrol. 2011, 26: 1523-1527. doi: 10.1007/s00467-011-1823-z
49. Martinez-Zaguilan, R., Lynch, R. M., Martinez, G. M., and Gillies, R. J., Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 1993. 265: C1015-1029.
50. Martínez-Zaguilán, R., Gillies, R. J., A plasma membrane V-type H(+)-ATPase may contribute to elevated intracellular pH (pHin) in some human tumor cells. Ann. N. Y. Acad. Sci 1992, 671: 478-480. doi: 10.1111/j.1749-6632.1992.tb43834.x
51. Nguyen, G., Renin, (pro)renin and receptor: an update. Clin. Sci. (Lond) 2011, 120: 169-178. doi: 10.1042/CS20100432